Therapeutic treatment with Ibrutinib attenuates imiquimod-induced psoriasis-like inflammation in mice through downregulation of oxidative and inflammatory mediators in neutrophils and dendritic cells
Naif O. Al‐Harbi, Ahmed Nadeem, Sheikh F. Ahmad, Saleh A. Bakheet, Ahmed M. El‐Sherbeeny, Khalid E. Ibrahim, Khalid S. Alzahrani, Mohammed M. Al‐Harbi, Hafiz Majid Mahmood, Faleh Alqahtani, Sabry M. Attia, Moureq R. Alotaibi
Topics & Concepts
ImiquimodPsoriasisInflammationIbrutinibDownregulation and upregulationMedicineImmunologyPharmacologyChemistryLeukemiaGeneBiochemistryChronic lymphocytic leukemiaChronic Lymphocytic Leukemia ResearchPsoriasis: Treatment and PathogenesisAutoimmune Bullous Skin Diseases